CA
ESRX

Cullinan Associates’s Express Scripts Holding Company ESRX Stock Holding History

Cullinan Associates’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-46,590
Closed -$3.48M – 191
2017
Q4 		$3.48M Sell
46,590
-8,400
-15% -$537K 0.26% 98
2017
Q3 		$3.48M Sell
54,990
-2,050
-4% -$127K 0.27% 97
2017
Q2 		$3.64M Sell
57,040
-1,285
-2% -$80.7K 0.28% 88
2017
Q1 		$3.84M Sell
58,325
-2,300
-4% -$158K 0.31% 85
2016
Q4 		$4.17M Sell
60,625
-5,355
-8% -$384K 0.36% 79
2016
Q3 		$4.65M Hold
65,980
– – 0.4% 73
2016
Q2 		$5M Buy
65,980
+200
+0.3% +$14.7K 0.41% 69
2016
Q1 		$4.52M Hold
65,780
– – 0.39% 72
2015
Q4 		$5.75M Buy
65,780
+1,240
+2% +$106K 0.5% 51
2015
Q3 		$5.22M Buy
64,540
+3,909
+6% +$340K 0.48% 52
2015
Q2 		$5.39M Buy
60,631
+18,050
+42% +$1.58M 0.44% 55
2015
Q1 		$3.69M Buy
+42,581
New +$3.57M 0.29% 74

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cullinan Associates's ESRX Position: Q1 2018 in Review

Cullinan Associates sold out of Express Scripts Holding Company (ESRX) in Q1 2018, closing a stake of 46,590 shares — an estimated $3.48M sold.

Cullinan Associates first reported a position in ESRX in Q1 2015 and held it in 12 quarters. The position peaked at $5.75M in Q4 2015. 1,119 funds tracked by Wall St. Rank hold ESRX as of Q1 2018.

  • Cullinan Associates reported no remaining Express Scripts Holding Company position as of Q1 2018 after selling out during the quarter.
  • Cullinan Associates sold 46,590 Express Scripts Holding Company shares in Q1 2018, an estimated $3.48M.
  • Cullinan Associates first reported a position in Express Scripts Holding Company in Q1 2015 and held it in 12 quarters.
  • Cullinan Associates's Express Scripts Holding Company position peaked at $5.75M in Q4 2015.
  • 1,119 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2018.

Based on Cullinan Associates's 13F filing for Q1 2018, filed 27 Apr 2018.